Atea Pharmaceuticals, Inc. (AVIR) Q1 2024 Earnings
AVIR·Reported May 14, 2024·After market close
Diluted EPS came in at $-0.75, missed the $-0.61 consensus by $0.14.
Diluted EPS
$-0.75missed by $0.14
Consensus: $-0.61
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Atea Pharmaceuticals, Inc.'s Q1 2024 earnings report.
Atea Pharmaceuticals, Inc. (AVIR) reported Q1 2024 earnings on May 14, 2024 after market close.
Atea Pharmaceuticals, Inc. reported diluted EPS of $-0.75 for Q1 2024.
EPS missed the consensus estimate of $-0.61 by $0.14.
You can read the 10-Q periodic report (0000950170-24-059699) directly on SEC EDGAR. The filing index links above go to sec.gov.